-
1
-
-
34447538141
-
High-throughput screening assays for the identification of chemical probes
-
Inglese J, Johnson RL, Simeonov A, et al. High-throughput screening assays for the identification of chemical probes. Nat Chem Biol. 2007;3:466-479.
-
(2007)
Nat Chem Biol.
, vol.3
, pp. 466-479
-
-
Inglese, J.1
Johnson, R.L.2
Simeonov, A.3
-
2
-
-
0038387389
-
Hit and lead generation: Beyond high-throughput screening
-
Bleicher KH, Böhm HJ, Müller K, Alanine AI. Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov. 2003;2(5):369-378.
-
(2003)
Nat Rev Drug Discov.
, vol.2
, Issue.5
, pp. 369-378
-
-
Bleicher, K.H.1
Böhm, H.J.2
Müller, K.3
Alanine, A.I.4
-
3
-
-
84858232188
-
Nature Outlook: Hepatitis C
-
Nature Outlook: Hepatitis C. Nature. 2011;474:S1-S21.
-
(2011)
Nature.
, vol.474
, pp. S1-S21
-
-
-
5
-
-
84874107832
-
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
-
Lange CM, Zeuzem S. Perspectives and challenges of interferon-free therapy for chronic hepatitis C. J Hepatol. 2013;58(3):583-592.
-
(2013)
J Hepatol.
, vol.58
, Issue.3
, pp. 583-592
-
-
Lange, C.M.1
Zeuzem, S.2
-
6
-
-
79953176289
-
Boceprevir for previously treated chronic HCV genotype 1 infection
-
Bacon BR, Gordon, SC, Lawitz E, et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med. 2011;364(13):1207-1217.
-
(2011)
N Engl J Med.
, vol.364
, Issue.13
, pp. 1207-1217
-
-
Bacon, B.R.1
Gordon, S.C.2
Lawitz, E.3
-
7
-
-
79959438789
-
Telaprevir for previously untreated chronic hepatitis C virus infection
-
Jacobson IM, McHutchison JG, Dusheiko G, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med. 2011;364(25):2405-2416.
-
(2011)
N Engl J Med.
, vol.364
, Issue.25
, pp. 2405-2416
-
-
Jacobson, I.M.1
McHutchison, J.G.2
Dusheiko, G.3
-
8
-
-
79953173221
-
Boceprevir for untreated chronic HCV genotype 1 infection
-
Poordad F, McCone J Jr, Bacon BR, et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med. 2011;364(13):1195-1206.
-
(2011)
N Engl J Med.
, vol.364
, Issue.13
, pp. 1195-1206
-
-
Poordad, F.1
McCone, J.2
Bacon, B.R.3
-
9
-
-
79959381354
-
Telaprevir for retreatment of HCV infection
-
Zeuzem S, Andreone P, Pol S, et al. Telaprevir for retreatment of HCV infection. N Engl J Med. 2011;364(25):2417-2428.
-
(2011)
N Engl J Med.
, vol.364
, Issue.25
, pp. 2417-2428
-
-
Zeuzem, S.1
Andreone, P.2
Pol, S.3
-
10
-
-
84894297488
-
Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection
-
Gane EJ, Stedman CA, Hyland RH, et al. Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection. Gastroenterology. 2014;146(3):736-743.
-
(2014)
Gastroenterology.
, vol.146
, Issue.3
, pp. 736-743
-
-
Gane, E.J.1
Stedman, C.A.2
Hyland, R.H.3
-
11
-
-
84896266984
-
Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor
-
Rosenquist Å, Samuelsson B, Johansson PO, et al. Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor. J Med Chem. 2014;57(5):1673-1693.
-
(2014)
J Med Chem.
, vol.57
, Issue.5
, pp. 1673-1693
-
-
Rosenquist, Å.1
Samuelsson, B.2
Johansson, P.O.3
-
12
-
-
84896479169
-
Advances in interferon-free hepatitis C therapy: 2014 and beyond
-
Sarkar S, Lim JK. Advances in interferon-free hepatitis C therapy: 2014 and beyond. Hepatology. 2014;59(4):1641-1644.
-
(2014)
Hepatology.
, vol.59
, Issue.4
, pp. 1641-1644
-
-
Sarkar, S.1
Lim, J.K.2
-
13
-
-
70349330154
-
Thermodynamics of zinc binding to hepatitis C virus NS3 protease: A folding by binding event
-
Abian O, Neira JL, Velazquez-Campoy A. Thermodynamics of zinc binding to hepatitis C virus NS3 protease: A folding by binding event. Proteins. 2009;77(3):624-636.
-
(2009)
Proteins.
, vol.77
, Issue.3
, pp. 624-636
-
-
Abian, O.1
Neira, J.L.2
Velazquez-Campoy, A.3
-
14
-
-
78649898944
-
Conformational stability of hepatitis C virus NS3 protease
-
Abian O, Vega S, Neira JL, Velazquez-Campoy A. Conformational stability of hepatitis C virus NS3 protease. Biophys J. 2010;99(11):3811-3820.
-
(2010)
Biophys J.
, vol.99
, Issue.11
, pp. 3811-3820
-
-
Abian, O.1
Vega, S.2
Neira, J.L.3
Velazquez-Campoy, A.4
-
15
-
-
84880845826
-
Allosteric Inhibitors of the NS3 Protease From the Hepatitis C Virus
-
Abian O, Vega S, Sancho J, Velazquez-Campoy A. Allosteric Inhibitors of the NS3 Protease From the Hepatitis C Virus. PLoS One. 2013;8(7):e69773.
-
(2013)
PLoS One.
, vol.8
, Issue.7
-
-
Abian, O.1
Vega, S.2
Sancho, J.3
Velazquez-Campoy, A.4
-
16
-
-
11644249583
-
Cyclodextrins and their applications in analytical chemistry
-
Li S, Purdy WC. Cyclodextrins and their applications in analytical chemistry. Chem Rev. 1992;92(6):1457-1470.
-
(1992)
Chem Rev.
, vol.92
, Issue.6
, pp. 1457-1470
-
-
Li, S.1
Purdy, W.C.2
-
17
-
-
0001627521
-
Sur la fermentation de la fecule par l'action du ferment butyrique
-
French
-
Villiers A. Sur la fermentation de la fecule par l'action du ferment butyrique [The fermentation of starch by the action of butyric]. C R Acad Sci. 1981;112:536-538. French.
-
(1981)
C R Acad Sci.
, vol.112
, pp. 536-538
-
-
Villiers, A.1
-
18
-
-
84985609923
-
Cyclodextrin inclusion compounds in research and industry
-
Saenger W. Cyclodextrin inclusion compounds in research and industry. Angew Chem Int Ed Engl. 1980;19(5):344-362.
-
(1980)
Angew Chem Int Ed Engl.
, vol.19
, Issue.5
, pp. 344-362
-
-
Saenger, W.1
-
19
-
-
0032119526
-
Cyclodextrin drug carrier systems
-
Uekama K, Hirayama F, Irie T. Cyclodextrin drug carrier systems. Chem Rev. 1998;98(5):2045-2076.
-
(1998)
Chem Rev.
, vol.98
, Issue.5
, pp. 2045-2076
-
-
Uekama, K.1
Hirayama, F.2
Irie, T.3
-
20
-
-
0036890313
-
Biotechnological applications of cyclodextrins
-
Singh M, Sharma R, Banerjee UC. Biotechnological applications of cyclodextrins. Biotechnol Adv. 2002;20(5-6):341-359.
-
(2002)
Biotechnol Adv.
, vol.20
, Issue.5-6
, pp. 341-359
-
-
Singh, M.1
Sharma, R.2
Banerjee, U.C.3
-
21
-
-
34547471499
-
Supramolecular chemistry of cyclodextrins in enzyme technology
-
Villalonga R, Cao R, Fragoso A. Supramolecular chemistry of cyclodextrins in enzyme technology. Chem Rev. 2007;107(7):3088-3116.
-
(2007)
Chem Rev.
, vol.107
, Issue.7
, pp. 3088-3116
-
-
Villalonga, R.1
Cao, R.2
Fragoso, A.3
-
22
-
-
4243778369
-
Complexation thermodynamics of cyclodextrins
-
Rekharsky MV, Inoue Y. Complexation thermodynamics of cyclodextrins. Chem Rev. 1998;98(5):875-1917.
-
(1998)
Chem Rev.
, vol.98
, Issue.5
, pp. 875-1917
-
-
Rekharsky, M.V.1
Inoue, Y.2
-
23
-
-
33748232757
-
Multinuclear sandwich-type complexes of deprotonated β-cyclodextrin and copper(II) ions
-
Fuchs R, Habermann N, Klufers P. Multinuclear sandwich-type complexes of deprotonated β-cyclodextrin and copper(II) ions. Angew Chem Int Ed Eng. 1993;32(6):852-854.
-
(1993)
Angew Chem Int Ed Eng.
, vol.32
, Issue.6
, pp. 852-854
-
-
Fuchs, R.1
Habermann, N.2
Klufers, P.3
-
24
-
-
0033105151
-
Cyclodextrins in peptide and protein delivery
-
Irie T, Uekama K. Cyclodextrins in peptide and protein delivery. Adv Drug Deliv Rev. 1999;36(1):101-123.
-
(1999)
Adv Drug Deliv Rev.
, vol.36
, Issue.1
, pp. 101-123
-
-
Irie, T.1
Uekama, K.2
-
25
-
-
0043212038
-
Innovations in oligonucleotide drug delivery
-
Lysik MA, Wu-Pong S. Innovations in oligonucleotide drug delivery. J Pharm Sci. 2003;92(8):1559-1573.
-
(2003)
J Pharm Sci.
, vol.92
, Issue.8
, pp. 1559-1573
-
-
Lysik, M.A.1
Wu-Pong, S.2
-
26
-
-
0031054513
-
Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation
-
Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci. 1997;86(2):147-162.
-
(1997)
J Pharm Sci.
, vol.86
, Issue.2
, pp. 147-162
-
-
Irie, T.1
Uekama, K.2
-
27
-
-
34548134519
-
Cyclodextrins as pharmaceutical solubilizers
-
Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev. 2007;59(7):645-666.
-
(2007)
Adv Drug Deliv Rev.
, vol.59
, Issue.7
, pp. 645-666
-
-
Brewster, M.E.1
Loftsson, T.2
-
28
-
-
35248822616
-
The utility of cyclodextrins for enhancing oral bioavailability
-
Carrier RL, Miller LA, Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J Control Release. 2007;123(2):78-99.
-
(2007)
J Control Release.
, vol.123
, Issue.2
, pp. 78-99
-
-
Carrier, R.L.1
Miller, L.A.2
Ahmed, I.3
-
29
-
-
0033104290
-
Cyclodextrin-based controlled drug release system
-
Hirayama F, Uekama K. Cyclodextrin-based controlled drug release system. Adv Drug Deliv Rev. 1999;36(1):125-141.
-
(1999)
Adv Drug Deliv Rev.
, vol.36
, Issue.1
, pp. 125-141
-
-
Hirayama, F.1
Uekama, K.2
-
30
-
-
10444279209
-
Cyclodextrin-based pharmaceutics: Past, present, and future
-
Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present, and future. Nat Rev Drug Discov. 2004;3(12):1023-1035.
-
(2004)
Nat Rev Drug Discov.
, vol.3
, Issue.12
, pp. 1023-1035
-
-
Davis, M.E.1
Brewster, M.E.2
-
31
-
-
80051674971
-
Pharmaceutical applications of cyclodextrins: Effects on drug permeation through biological membranes
-
Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes. J Pharm Pharmacol. 2011;63(9):1119-1135.
-
(2011)
J Pharm Pharmacol.
, vol.63
, Issue.9
, pp. 1119-1135
-
-
Loftsson, T.1
Brewster, M.E.2
-
32
-
-
0033106031
-
Cyclodextrins in transdermal and rectal delivery
-
Matsuda H, Arima H. Cyclodextrins in transdermal and rectal delivery. Adv Drug Deliv Rev. 1999;36(1):80-99.
-
(1999)
Adv Drug Deliv Rev.
, vol.36
, Issue.1
, pp. 80-99
-
-
Matsuda, H.1
Arima, H.2
-
33
-
-
0344286485
-
Cyclodextrins in ophthalmic drug delivery
-
Loftsson T, Jarvinen T. Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev. 1999;36(1):59-79.
-
(1999)
Adv Drug Deliv Rev.
, vol.36
, Issue.1
, pp. 59-79
-
-
Loftsson, T.1
Jarvinen, T.2
-
35
-
-
0033106020
-
Highly soluble cyclodextrin derivatives: Chemistry, properties, and trends in development
-
Szente L, Szejtli J. Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv Drug Deliv Rev. 1999;36(1):17-28.
-
(1999)
Adv Drug Deliv Rev.
, vol.36
, Issue.1
, pp. 17-28
-
-
Szente, L.1
Szejtli, J.2
-
36
-
-
0032590348
-
Cyclodextrins in targeting application to nanoparticles
-
Duchene D, Ponchel G, Wouessidjewe D. Cyclodextrins in targeting application to nanoparticles. Adv Drug Deliv Rev. 1999;36(1):29-40.
-
(1999)
Adv Drug Deliv Rev.
, vol.36
, Issue.1
, pp. 29-40
-
-
Duchene, D.1
Ponchel, G.2
Wouessidjewe, D.3
-
38
-
-
33845573098
-
Cyclodextrins and their pharmaceutical applications
-
Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 2007;329(1-2):1-11.
-
(2007)
Int J Pharm.
, vol.329
, Issue.1-2
, pp. 1-11
-
-
Loftsson, T.1
Duchene, D.2
-
39
-
-
3543018550
-
Inclusion complexes of Rose Bengal and cyclodextrins
-
Fini P, Castagnolo M, Catucci L, Cosma P, Agostiano A. Inclusion complexes of Rose Bengal and cyclodextrins. Thermochim Acta. 2004;418:33-38.
-
(2004)
Thermochim Acta.
, vol.418
, pp. 33-38
-
-
Fini, P.1
Castagnolo, M.2
Catucci, L.3
Cosma, P.4
Agostiano, A.5
-
40
-
-
33646765256
-
A study of a-cyclodextrin with a group of cationic Gemini surfactants utilizing isothermal titration calorimetry and NMR
-
Sun DZ, Qiu XM, Li L, Wei XL, Yin BL. A study of a-cyclodextrin with a group of cationic Gemini surfactants utilizing isothermal titration calorimetry and NMR. J Chem Thermodyn. 2006;38(6):773-777.
-
(2006)
J Chem Thermodyn.
, vol.38
, Issue.6
, pp. 773-777
-
-
Sun, D.Z.1
Qiu, X.M.2
Li, L.3
Wei, X.L.4
Yin, B.L.5
-
41
-
-
39649095630
-
Effect of b-cyclodextrin charge type on the molecular recognition thermodynamics of reactions with (ferrocenylmethyl)dimethylaminium derivatives
-
Liu Y, Cao R, Chen Y, He JY. Effect of b-cyclodextrin charge type on the molecular recognition thermodynamics of reactions with (ferrocenylmethyl)dimethylaminium derivatives. J Phys Chem B. 2008;112(5):1445-1450.
-
(2008)
J Phys Chem B.
, vol.112
, Issue.5
, pp. 1445-1450
-
-
Liu, Y.1
Cao, R.2
Chen, Y.3
He, J.Y.4
-
42
-
-
34548192170
-
Supramolecular self-assembly of b-cyclodextrin: An effective carrier of the antimicrobial agent chlorhexidine
-
Denadai AM, Teixeira KI, Santoro MM, Pimenta AM, Cortes ME, Sinisterra RD. Supramolecular self-assembly of b-cyclodextrin: an effective carrier of the antimicrobial agent chlorhexidine. Carbohydr Res. 2007;342(15):2286-2296.
-
(2007)
Carbohydr Res.
, vol.342
, Issue.15
, pp. 2286-2296
-
-
Denadai, A.M.1
Teixeira, K.I.2
Santoro, M.M.3
Pimenta, A.M.4
Cortes, M.E.5
Sinisterra, R.D.6
-
43
-
-
40549101840
-
Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system
-
He Y, King MS, Kempf DJ, et al. Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system. Antimicrob Agents Chemother. 2008;52(3):1101-1110.
-
(2008)
Antimicrob Agents Chemother.
, vol.52
, Issue.3
, pp. 1101-1110
-
-
He, Y.1
King, M.S.2
Kempf, D.J.3
-
44
-
-
73449083030
-
Discovery of specific flavodoxin inhibitors as potential therapeutic agents against Helicobacter pylori infection
-
Cremades N, Velazquez-Campoy A, Martinez-Julvez M, et al. Discovery of specific flavodoxin inhibitors as potential therapeutic agents against Helicobacter pylori infection. ACS Chem Biol. 2009;4(11):928-938.
-
(2009)
ACS Chem Biol.
, vol.4
, Issue.11
, pp. 928-938
-
-
Cremades, N.1
Velazquez-Campoy, A.2
Martinez-Julvez, M.3
-
45
-
-
48749132287
-
Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria
-
Pey AL, Ying M, Cremades N, et al. Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria. J Clin Invest. 2008;118(8):2858-2867.
-
(2008)
J Clin Invest.
, vol.118
, Issue.8
, pp. 2858-2867
-
-
Pey, A.L.1
Ying, M.2
Cremades, N.3
-
46
-
-
0030586870
-
A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates
-
Taliani M, Bianchi E, Narjes F, et al. A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates. Anal Biochem. 1996;240(1):60-67.
-
(1996)
Anal Biochem.
, vol.240
, Issue.1
, pp. 60-67
-
-
Taliani, M.1
Bianchi, E.2
Narjes, F.3
-
47
-
-
11644261806
-
Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function
-
Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. 1998;19:1639-1662.
-
(1998)
J Comput Chem.
, vol.19
, pp. 1639-1662
-
-
Morris, G.M.1
Goodsell, D.S.2
Halliday, R.S.3
-
49
-
-
33750947650
-
Resistance of hepatitis C virus to NS3-4A protease inhibitors: Mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations
-
Courcambeck J, Bouzidi M, Perbost R, et al. Resistance of hepatitis C virus to NS3-4A protease inhibitors: Mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations. Antivir Ther. 2004;11(7):847-855.
-
(2004)
Antivir Ther.
, vol.11
, Issue.7
, pp. 847-855
-
-
Courcambeck, J.1
Bouzidi, M.2
Perbost, R.3
-
50
-
-
82755182674
-
Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir
-
Susser S, Vermehren J, Forestier N, et al. Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir. J Clin Virol. 2011;52(4):321-327.
-
(2011)
J Clin Virol.
, vol.52
, Issue.4
, pp. 321-327
-
-
Susser, S.1
Vermehren, J.2
Forestier, N.3
-
51
-
-
0036893332
-
Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication
-
Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol. 2002;76(24):13001-13014.
-
(2002)
J Virol.
, vol.76
, Issue.24
, pp. 13001-13014
-
-
Blight, K.J.1
McKeating, J.A.2
Rice, C.M.3
-
52
-
-
0345188811
-
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
-
Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999;285(5424):110-113.
-
(1999)
Science.
, vol.285
, Issue.5424
, pp. 110-113
-
-
Lohmann, V.1
Korner, F.2
Koch, J.3
Herian, U.4
Theilmann, L.5
Bartenschlager, R.6
-
53
-
-
0032563197
-
The metal binding site of the hepatitis C virus NS3 protease. A spectroscopic investigation
-
Urbani A, Bazzo R, Nardi MC, et al. The metal binding site of the hepatitis C virus NS3 protease. A spectroscopic investigation. J Biol Chem. 1998;273(30):18760-18769.
-
(1998)
J Biol Chem.
, vol.273
, Issue.30
, pp. 18760-18769
-
-
Urbani, A.1
Bazzo, R.2
Nardi, M.C.3
-
54
-
-
84890955045
-
NS3 protease from hepatitis C virus: Biophysical studies on an intrinsically disordered protein domain
-
Vega S, Neira JL, Marcuello C, et al. NS3 protease from hepatitis C virus: Biophysical studies on an intrinsically disordered protein domain. Int J Mol Sci. 2013;14(7):13282-13306.
-
(2013)
Int J Mol Sci.
, vol.14
, Issue.7
, pp. 13282-13306
-
-
Vega, S.1
Neira, J.L.2
Marcuello, C.3
|